Identification of ACA-28, a 1′-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cells

Ryosuke Satoh, Kanako Hagihara, Kazuki Matsuura, Yoshiaki Manse, Ayako Kita, Tatsuki Kunoh, Takashi Masuko, Mariko Moriyama, Hiroyuki Moriyama, Genzoh Tanabe, Osamu Muraoka, Reiko Sugiura

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The extracellular signal-regulated kinase (ERK) signaling pathway is essential for cell proliferation and is frequently deregulated in human tumors such as melanoma. Melanoma remains incurable despite the use of conventional chemotherapy; consequently, development of new therapeutic agents for melanoma is highly desirable. Here, we carried out a chemical genetic screen using a fission yeast phenotypic assay and showed that ACA-28, a synthetic derivative of 1′-acetoxychavicol acetate (ACA), which is a natural ginger compound, effectively inhibited the growth of melanoma cancer cells wherein ERK MAPK signaling is hyperactivated due to mutations in the upstream activating regulators. ACA-28 more potently inhibited the growth of melanoma cells than did the parental compound ACA. Importantly, the growth of normal human epidermal melanocytes (NHEM) was less affected by ACA-28 at the same 50% inhibitory concentration. In addition, ACA-28 specifically induced apoptosis in NIH/3T3 cells which were oncogenically transformed with human epidermal growth factor receptor-2 (HER2/ErbB2), but not in the parental cells. Notably, the ACA-28-induced apoptosis in melanoma and HER2-transformed cells was abrogated when ERK activation was blocked with a specific MEK inhibitor U0126. Consistently, ACA-28 more strongly stimulated ERK phosphorylation in melanoma cells, as compared in NHEM. ACA-28 might serve as a promising seed compound for melanoma treatment.

Original languageEnglish
Pages (from-to)608-618
Number of pages11
JournalGenes to Cells
Volume22
Issue number7
DOIs
Publication statusPublished - Jul 1 2017

Fingerprint

Extracellular Signal-Regulated MAP Kinases
Melanoma
Acetates
Melanocytes
Growth
Apoptosis
Ginger
NIH 3T3 Cells
1'-acetoxychavicol acetate
Schizosaccharomyces
Mitogen-Activated Protein Kinase Kinases
Inhibitory Concentration 50
Neoplasms
Seeds
Phosphorylation
Cell Proliferation
Drug Therapy
Mutation
Therapeutics

ASJC Scopus subject areas

  • Genetics
  • Cell Biology

Cite this

Identification of ACA-28, a 1′-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cells. / Satoh, Ryosuke; Hagihara, Kanako; Matsuura, Kazuki; Manse, Yoshiaki; Kita, Ayako; Kunoh, Tatsuki; Masuko, Takashi; Moriyama, Mariko; Moriyama, Hiroyuki; Tanabe, Genzoh; Muraoka, Osamu; Sugiura, Reiko.

In: Genes to Cells, Vol. 22, No. 7, 01.07.2017, p. 608-618.

Research output: Contribution to journalArticle

Satoh, R, Hagihara, K, Matsuura, K, Manse, Y, Kita, A, Kunoh, T, Masuko, T, Moriyama, M, Moriyama, H, Tanabe, G, Muraoka, O & Sugiura, R 2017, 'Identification of ACA-28, a 1′-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cells', Genes to Cells, vol. 22, no. 7, pp. 608-618. https://doi.org/10.1111/gtc.12499
Satoh, Ryosuke ; Hagihara, Kanako ; Matsuura, Kazuki ; Manse, Yoshiaki ; Kita, Ayako ; Kunoh, Tatsuki ; Masuko, Takashi ; Moriyama, Mariko ; Moriyama, Hiroyuki ; Tanabe, Genzoh ; Muraoka, Osamu ; Sugiura, Reiko. / Identification of ACA-28, a 1′-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cells. In: Genes to Cells. 2017 ; Vol. 22, No. 7. pp. 608-618.
@article{f88f10d2509541f9a04fecec1e2fa7e7,
title = "Identification of ACA-28, a 1′-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cells",
abstract = "The extracellular signal-regulated kinase (ERK) signaling pathway is essential for cell proliferation and is frequently deregulated in human tumors such as melanoma. Melanoma remains incurable despite the use of conventional chemotherapy; consequently, development of new therapeutic agents for melanoma is highly desirable. Here, we carried out a chemical genetic screen using a fission yeast phenotypic assay and showed that ACA-28, a synthetic derivative of 1′-acetoxychavicol acetate (ACA), which is a natural ginger compound, effectively inhibited the growth of melanoma cancer cells wherein ERK MAPK signaling is hyperactivated due to mutations in the upstream activating regulators. ACA-28 more potently inhibited the growth of melanoma cells than did the parental compound ACA. Importantly, the growth of normal human epidermal melanocytes (NHEM) was less affected by ACA-28 at the same 50{\%} inhibitory concentration. In addition, ACA-28 specifically induced apoptosis in NIH/3T3 cells which were oncogenically transformed with human epidermal growth factor receptor-2 (HER2/ErbB2), but not in the parental cells. Notably, the ACA-28-induced apoptosis in melanoma and HER2-transformed cells was abrogated when ERK activation was blocked with a specific MEK inhibitor U0126. Consistently, ACA-28 more strongly stimulated ERK phosphorylation in melanoma cells, as compared in NHEM. ACA-28 might serve as a promising seed compound for melanoma treatment.",
author = "Ryosuke Satoh and Kanako Hagihara and Kazuki Matsuura and Yoshiaki Manse and Ayako Kita and Tatsuki Kunoh and Takashi Masuko and Mariko Moriyama and Hiroyuki Moriyama and Genzoh Tanabe and Osamu Muraoka and Reiko Sugiura",
year = "2017",
month = "7",
day = "1",
doi = "10.1111/gtc.12499",
language = "English",
volume = "22",
pages = "608--618",
journal = "Genes to Cells",
issn = "1356-9597",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Identification of ACA-28, a 1′-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cells

AU - Satoh, Ryosuke

AU - Hagihara, Kanako

AU - Matsuura, Kazuki

AU - Manse, Yoshiaki

AU - Kita, Ayako

AU - Kunoh, Tatsuki

AU - Masuko, Takashi

AU - Moriyama, Mariko

AU - Moriyama, Hiroyuki

AU - Tanabe, Genzoh

AU - Muraoka, Osamu

AU - Sugiura, Reiko

PY - 2017/7/1

Y1 - 2017/7/1

N2 - The extracellular signal-regulated kinase (ERK) signaling pathway is essential for cell proliferation and is frequently deregulated in human tumors such as melanoma. Melanoma remains incurable despite the use of conventional chemotherapy; consequently, development of new therapeutic agents for melanoma is highly desirable. Here, we carried out a chemical genetic screen using a fission yeast phenotypic assay and showed that ACA-28, a synthetic derivative of 1′-acetoxychavicol acetate (ACA), which is a natural ginger compound, effectively inhibited the growth of melanoma cancer cells wherein ERK MAPK signaling is hyperactivated due to mutations in the upstream activating regulators. ACA-28 more potently inhibited the growth of melanoma cells than did the parental compound ACA. Importantly, the growth of normal human epidermal melanocytes (NHEM) was less affected by ACA-28 at the same 50% inhibitory concentration. In addition, ACA-28 specifically induced apoptosis in NIH/3T3 cells which were oncogenically transformed with human epidermal growth factor receptor-2 (HER2/ErbB2), but not in the parental cells. Notably, the ACA-28-induced apoptosis in melanoma and HER2-transformed cells was abrogated when ERK activation was blocked with a specific MEK inhibitor U0126. Consistently, ACA-28 more strongly stimulated ERK phosphorylation in melanoma cells, as compared in NHEM. ACA-28 might serve as a promising seed compound for melanoma treatment.

AB - The extracellular signal-regulated kinase (ERK) signaling pathway is essential for cell proliferation and is frequently deregulated in human tumors such as melanoma. Melanoma remains incurable despite the use of conventional chemotherapy; consequently, development of new therapeutic agents for melanoma is highly desirable. Here, we carried out a chemical genetic screen using a fission yeast phenotypic assay and showed that ACA-28, a synthetic derivative of 1′-acetoxychavicol acetate (ACA), which is a natural ginger compound, effectively inhibited the growth of melanoma cancer cells wherein ERK MAPK signaling is hyperactivated due to mutations in the upstream activating regulators. ACA-28 more potently inhibited the growth of melanoma cells than did the parental compound ACA. Importantly, the growth of normal human epidermal melanocytes (NHEM) was less affected by ACA-28 at the same 50% inhibitory concentration. In addition, ACA-28 specifically induced apoptosis in NIH/3T3 cells which were oncogenically transformed with human epidermal growth factor receptor-2 (HER2/ErbB2), but not in the parental cells. Notably, the ACA-28-induced apoptosis in melanoma and HER2-transformed cells was abrogated when ERK activation was blocked with a specific MEK inhibitor U0126. Consistently, ACA-28 more strongly stimulated ERK phosphorylation in melanoma cells, as compared in NHEM. ACA-28 might serve as a promising seed compound for melanoma treatment.

UR - http://www.scopus.com/inward/record.url?scp=85019119054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019119054&partnerID=8YFLogxK

U2 - 10.1111/gtc.12499

DO - 10.1111/gtc.12499

M3 - Article

C2 - 28485554

AN - SCOPUS:85019119054

VL - 22

SP - 608

EP - 618

JO - Genes to Cells

JF - Genes to Cells

SN - 1356-9597

IS - 7

ER -